Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-06-06

FDA Approved: GLEOLAN — Original Application (Medexus Pharma, Inc.)

View source ↗

Summary

The FDA approved Gleolan (aminolevulinic acid hydrochloride) from Medexus Pharma under NDA208630 for use in fluorescence-guided visualization of malignant gliom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gleolan (5-aminolevulinic acid hydrochloride)

Snippet

ORIG AP for GLEOLAN (AMINOLEVULINIC ACID HYDROCHLORIDE)